DOPAMINE D2 RECEPTOR GENE (DRD2) HAPLOTYPES AND THE DEFENSE STYLE QUESTIONNAIRE IN SUBSTANCE-ABUSE, TOURETTE SYNDROME, AND CONTROLS

被引:28
作者
COMINGS, DE [1 ]
MACMURRAY, J [1 ]
JOHNSON, P [1 ]
DIETZ, G [1 ]
MUHLEMAN, D [1 ]
机构
[1] JERRY L PETTIS MEM VET ADM MED CTR, LOMA LINDA, CA USA
关键词
DOPAMINE; RECEPTOR; GENETIC; DEFENSE STYLE QUESTIONNAIRE; TOURETTE SYNDROME; SUBSTANCE ABUSE;
D O I
10.1016/0006-3223(94)00222-O
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The defense style questionnaire (DSQ) was administered to Caucasian males consisting of 123 subjects from a V.A. addiction treatment unit (ATU), 42 Tourette syndrome (TS) subjects, and 49 controls. For the ATU and TS subjects, there was a significant decrease in the mean. score for mature defenses and a significant increase in mean score for immature defenses compared to controls. Many of the individual subscores showed the same significant differences. Dopamine D2 receptor (DRD2) gene haplotypes, identified by allele specific polymerase chain reaction of two mutations (G/T and C/T) 241 base pairs apart, were determined in 57 of the ATU subjects and 42 of the controls. Subjects with the 1 haplotype tended to show a decrease in mature and an increase in neurotic and immature defense styles compared to those without the 1 haplotype. Of the eight times that the subscale scores were significant for haplotype 1 versus non-1, they were always in this direction. These results suggest that the DRD2 locus is one of the factors controlling defense styles. The difference in the mean scores between controls and substance abuse subjects indicates that other genes and environmental factors also play a role.
引用
收藏
页码:798 / 805
页数:8
相关论文
共 47 条
[11]  
Comings D. E., 1990, TOURETTE SYNDROME HU
[12]   THE DOPAMINE-D(2) RECEPTOR GENE - A GENETIC RISK FACTOR IN SUBSTANCE-ABUSE [J].
COMINGS, DE ;
MUHLEMAN, D ;
AHN, C ;
GYSIN, R ;
FLANAGAN, SD .
DRUG AND ALCOHOL DEPENDENCE, 1994, 34 (03) :175-180
[13]   THE DOPAMINE-D(2) RECEPTOR (DRD2) AS A MAJOR GENE IN OBESITY AND HEIGHT [J].
COMINGS, DE ;
FLANAGAN, SD ;
DIETZ, G ;
MUHLEMAN, D ;
KNELL, E ;
GYSIN, R .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1993, 50 (02) :176-185
[14]   THE DOPAMINE-D2 RECEPTOR LOCUS AS A MODIFYING GENE IN NEUROPSYCHIATRIC DISORDERS [J].
COMINGS, DE ;
COMINGS, BG ;
MUHLEMAN, D ;
DIETZ, G ;
SHAHBAHRAMI, B ;
TAST, D ;
KNELL, E ;
KOCSIS, P ;
BAUMGARTEN, R ;
KOVACS, BW ;
LEVY, DL ;
SMITH, M ;
BORISON, RL ;
EVANS, DD ;
KLEIN, DN ;
MACMURRAY, J ;
TOSK, JM ;
SVERD, J ;
GYSIN, R ;
FLANAGAN, SD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (13) :1793-1800
[15]   GENETIC-FACTORS IN SUBSTANCE-ABUSE BASED ON STUDIES OF TOURETTE-SYNDROME AND ADHD PROBANDS AND RELATIVES .2. ALCOHOL-ABUSE [J].
COMINGS, DE .
DRUG AND ALCOHOL DEPENDENCE, 1994, 35 (01) :17-24
[16]  
COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P281
[17]   GENETIC-FACTORS IN SUBSTANCE-ABUSE BASED ON STUDIES OF TOURETTE-SYNDROME AND ADHD PROBANDS AND RELATIVES .1. DRUG-ABUSE [J].
COMINGS, DE .
DRUG AND ALCOHOL DEPENDENCE, 1994, 35 (01) :1-16
[18]  
COMINGS DE, 1994, UNPUB DOPAMINE D2 RE
[19]  
COMINGS DE, 1994, UNPUB MOL GENETICS P
[20]  
FLANAGAN SD, JUN AM PSYCH SOC M L